Literature DB >> 6269546

Glycosylation of cell surface receptors: tunicamycin treatment decreases insulin and growth hormone binding to different levels in cultured lymphocytes.

L M Keefer, P De Meyts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269546     DOI: 10.1016/s0006-291x(81)80005-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

1.  The human growth hormone receptor of cultured human lymphocytes. Structural characteristics and glycosylation properties.

Authors:  K Asakawa; J A Hedo; A McElduff; D G Rouiller; M J Waters; P Gorden
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

2.  Saccharides mediate the attachment of rat macrophages to bone in vitro.

Authors:  Z Bar-Shavit; S L Teitelbaum; A J Kahn
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

3.  Tunicamycin inhibits ganglioside biosynthesis in neuronal cells.

Authors:  S P Guarnaccia; J H Shaper; R L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

4.  Effect of tunicamycin C2 on the induction of crystal induced chemotactic factor in human neutrophils.

Authors:  A K Bhatt; I Spilberg
Journal:  Agents Actions       Date:  1988-07

Review 5.  Growth hormone signal transduction.

Authors:  P Maharajan; V Maharajan
Journal:  Experientia       Date:  1993-11-15

6.  Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface.

Authors:  Max Brown; Samantha Dainty; Natalie Strudwick; Adina D Mihai; Jamie N Watson; Robina Dendooven; Adrienne W Paton; James C Paton; Martin Schröder
Journal:  Mol Biol Cell       Date:  2020-09-02       Impact factor: 4.138

7.  Effects of tunicamycin and various monosaccharides on phytohaemagglutinin-induced autorosette formation.

Authors:  S Hyodo; T Kishi; H Kashiwa; E Kittaka; T Suzawa; Y Tanaka; T Sakano; T Usui
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.